<DOC>
	<DOCNO>NCT01065805</DOCNO>
	<brief_summary>The Radiotracer 18F-FLT non-invasively assess excessive cell growth PET scan image . Tumour growth rate useful indicator tumour aggression response treatment . Imaging measure cell growth 18F-FLT may useful monitoring response anticancer treatment .</brief_summary>
	<brief_title>A Study Demonstrate Safety Preliminary Efficacy 18F-FLT Patients With Solid Tumours Lymphoma</brief_title>
	<detailed_description>Clinical trial combine Phase I/II imaging , open label , single site study patient know suspected carcinoma lung , breast , renal cell , pancreas brain , gastrointestinal malignancy , neuroendocrine tumour , lymphoma . One 18F-FLT PET scan perform 10 Phase I patient , pre-injection post-imaging blood work vital sign collect . Up 5 18F-FLT PET scan perform 170 Phase II patient .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Alovudine</mesh_term>
	<criteria>Male female great equal 16 year age . If female childbearing potential outside window 10 day since first day last menstrual period , negative pregnancy test require . Patients know primary suspect primary , recurrent metastatic carcinoma lung , breast , renal cell , pancreas brain ( include GGM , oligodendrogliomas , brain metastasis primary tumour ) gastrointestinal malignancy , neuroendocrine tumour ( include carcinoid islet cell malignancy , lymphoma , least one lesion &gt; 1 cm diameter . Biochemical parameter measure require within 5 time normal limit age . Able willing follow instruction comply protocol Provide write informed consent prior participation study Karnofsky Performance Scale Score 50100 Previous removal entire tumour Biochemical parameter measure outside 5 time normal limit age Unable unwilling follow instruction comply protocol Unable unwilling provide write informed consent prior participation study Karnofsky Performance Scale Score &lt; 50 Nursing pregnant female Age le 16 year</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>18F-FLT</keyword>
	<keyword>Positive Emission Tomography</keyword>
	<keyword>Cancer</keyword>
</DOC>